Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Intra- and inter-specific variation in alarm pheromone produced by Solenopsis fire ants.

Hu L, Balusu RR, Zhang WQ, Ajayi OS, Lu YY, Zeng RS, Fadamiro HY, Chen L.

Bull Entomol Res. 2017 Dec 10:1-7. doi: 10.1017/S0007485317001201. [Epub ahead of print]

PMID:
29223179
2.

When the good go bad: Mutant NPM1 in acute myeloid leukemia.

Kunchala P, Kuravi S, Jensen R, McGuirk J, Balusu R.

Blood Rev. 2017 Nov 4. pii: S0268-960X(17)30048-6. doi: 10.1016/j.blre.2017.11.001. [Epub ahead of print] Review.

PMID:
29157973
3.

Transmembrane Helices Tilt, Bend, Slide, Torque, and Unwind between Functional States of Rhodopsin.

Ren Z, Ren PX, Balusu R, Yang X.

Sci Rep. 2016 Sep 23;6:34129. doi: 10.1038/srep34129.

4.

1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).

Penthala NR, Ketkar A, Sekhar KR, Freeman ML, Eoff RL, Balusu R, Crooks PA.

Bioorg Med Chem. 2015 Nov 15;23(22):7226-33.

5.

Management of Yellowmargined Leaf Beetle Microtheca ochroloma (Coleoptera: Chrysomelidae) Using Turnip as a Trap Crop.

Balusu R, Rhodes E, Liburd O, Fadamiro H.

J Econ Entomol. 2015 Dec;108(6):2691-701. doi: 10.1093/jee/tov234. Epub 2015 Aug 4.

PMID:
26470380
6.

Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization.

Sekhar KR, Benamar M, Venkateswaran A, Sasi S, Penthala NR, Crooks PA, Hann SR, Geng L, Balusu R, Abbas T, Freeman ML.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1106-14. doi: 10.1016/j.ijrobp.2014.04.012. Epub 2014 Jul 8.

7.

Topical and vapor toxicity of saturated fatty acids to the German cockroach (Dictyoptera: Blattellidae).

Sims SR, Balusu RR, Ngumbi EN, Appel AG.

J Econ Entomol. 2014 Apr;107(2):758-63.

PMID:
24772558
8.

Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.

Fiskus W, Rao R, Balusu R, Ganguly S, Tao J, Sotomayor E, Mudunuru U, Smith JE, Hembruff SL, Atadja P, Marquez VE, Bhalla K.

Clin Cancer Res. 2012 Nov 15;18(22):6227-38. doi: 10.1158/1078-0432.CCR-12-0873. Epub 2012 Aug 29.

9.

Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.

Fiskus W, Hembruff SL, Rao R, Sharma P, Balusu R, Venkannagari S, Smith JE, Peth K, Peiper SC, Bhalla KN.

Breast Cancer Res Treat. 2012 Sep;135(2):433-44. doi: 10.1007/s10549-012-2171-9. Epub 2012 Jul 24.

PMID:
22825030
10.

Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.

Rao R, Balusu R, Fiskus W, Mudunuru U, Venkannagari S, Chauhan L, Smith JE, Hembruff SL, Ha K, Atadja P, Bhalla KN.

Mol Cancer Ther. 2012 Apr;11(4):973-83. doi: 10.1158/1535-7163.MCT-11-0979. Epub 2012 Feb 24.

12.
13.

Heat shock protein 90 inhibitor is synergistic with JAK2 inhibitor and overcomes resistance to JAK2-TKI in human myeloproliferative neoplasm cells.

Fiskus W, Verstovsek S, Manshouri T, Rao R, Balusu R, Venkannagari S, Rao NN, Ha K, Smith JE, Hembruff SL, Abhyankar S, McGuirk J, Bhalla KN.

Clin Cancer Res. 2011 Dec 1;17(23):7347-58. doi: 10.1158/1078-0432.CCR-11-1541. Epub 2011 Oct 5.

14.

Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.

Balusu R, Fiskus W, Rao R, Chong DG, Nalluri S, Mudunuru U, Ma H, Chen L, Venkannagari S, Ha K, Abhyankar S, Williams C, McGuirk J, Khoury HJ, Ustun C, Bhalla KN.

Blood. 2011 Sep 15;118(11):3096-106. doi: 10.1182/blood-2010-09-309674. Epub 2011 Jun 30.

15.

Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.

Ha K, Fiskus W, Rao R, Balusu R, Venkannagari S, Nalabothula NR, Bhalla KN.

Mol Cancer Ther. 2011 Jul;10(7):1194-206. doi: 10.1158/1535-7163.MCT-11-0094. Epub 2011 May 12.

16.

Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists.

Mandawat A, Fiskus W, Buckley KM, Robbins K, Rao R, Balusu R, Navenot JM, Wang ZX, Ustun C, Chong DG, Atadja P, Fujii N, Peiper SC, Bhalla K.

Blood. 2010 Dec 9;116(24):5306-15. doi: 10.1182/blood-2010-05-284414. Epub 2010 Sep 1.

17.

Heat shock protein 90 inhibition depletes TrkA levels and signaling in human acute leukemia cells.

Rao R, Nalluri S, Fiskus W, Balusu R, Joshi A, Mudunuru U, Buckley KM, Robbins K, Ustun C, Reuther GW, Bhalla KN.

Mol Cancer Ther. 2010 Aug;9(8):2232-42. doi: 10.1158/1535-7163.MCT-10-0336. Epub 2010 Jul 27.

18.

Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.

Rao R, Nalluri S, Fiskus W, Savoie A, Buckley KM, Ha K, Balusu R, Joshi A, Coothankandaswamy V, Tao J, Sotomayor E, Atadja P, Bhalla KN.

Clin Cancer Res. 2010 Oct 1;16(19):4742-54. doi: 10.1158/1078-0432.CCR-10-0529. Epub 2010 Jul 20.

19.

Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells.

Rao R, Nalluri S, Kolhe R, Yang Y, Fiskus W, Chen J, Ha K, Buckley KM, Balusu R, Coothankandaswamy V, Joshi A, Atadja P, Bhalla KN.

Mol Cancer Ther. 2010 Apr;9(4):942-52. doi: 10.1158/1535-7163.MCT-09-0988. Epub 2010 Apr 6.

20.

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells.

Wang Y, Fiskus W, Chong DG, Buckley KM, Natarajan K, Rao R, Joshi A, Balusu R, Koul S, Chen J, Savoie A, Ustun C, Jillella AP, Atadja P, Levine RL, Bhalla KN.

Blood. 2009 Dec 3;114(24):5024-33. doi: 10.1182/blood-2009-05-222133. Epub 2009 Oct 14.

21.

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.

Fiskus W, Wang Y, Sreekumar A, Buckley KM, Shi H, Jillella A, Ustun C, Rao R, Fernandez P, Chen J, Balusu R, Koul S, Atadja P, Marquez VE, Bhalla KN.

Blood. 2009 Sep 24;114(13):2733-43. doi: 10.1182/blood-2009-03-213496. Epub 2009 Jul 28.

22.

Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells.

Rao R, Lee P, Fiskus W, Yang Y, Joshi R, Wang Y, Buckley K, Balusu R, Chen J, Koul S, Joshi A, Upadhyay S, Tao J, Sotomayor E, Bhalla KN.

Cancer Biol Ther. 2009 Jul;8(13):1273-80.

23.

Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells.

Fiskus W, Buckley K, Rao R, Mandawat A, Yang Y, Joshi R, Wang Y, Balusu R, Chen J, Koul S, Joshi A, Upadhyay S, Atadja P, Bhalla KN.

Cancer Biol Ther. 2009 May;8(10):939-50. Epub 2009 May 18.

24.

Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.

Chen J, Fiskus W, Eaton K, Fernandez P, Wang Y, Rao R, Lee P, Joshi R, Yang Y, Kolhe R, Balusu R, Chappa P, Natarajan K, Jillella A, Atadja P, Bhalla KN.

Blood. 2009 Apr 23;113(17):4038-48. doi: 10.1182/blood-2008-08-176024. Epub 2008 Dec 12.

25.

C/EBPbeta-mediated transcriptional regulation of bcl-xl gene expression in human breast epithelial cells in response to cigarette smoke condensate.

Connors SK, Balusu R, Kundu CN, Jaiswal AS, Gairola CG, Narayan S.

Oncogene. 2009 Feb 12;28(6):921-32. doi: 10.1038/onc.2008.429. Epub 2008 Dec 1.

26.

Cotreatment with vorinostat enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous leukemia cells.

Fiskus W, Wang Y, Joshi R, Rao R, Yang Y, Chen J, Kolhe R, Balusu R, Eaton K, Lee P, Ustun C, Jillella A, Buser CA, Peiper S, Bhalla K.

Clin Cancer Res. 2008 Oct 1;14(19):6106-15. doi: 10.1158/1078-0432.CCR-08-0721.

27.

Structure/function analysis of the interaction of adenomatous polyposis coli with DNA polymerase beta and its implications for base excision repair.

Balusu R, Jaiswal AS, Armas ML, Kundu CN, Bloom LB, Narayan S.

Biochemistry. 2007 Dec 11;46(49):13961-74. Epub 2007 Nov 14.

PMID:
17999539
28.
29.

Mechanism of adenomatous polyposis coli (APC)-mediated blockage of long-patch base excision repair.

Jaiswal AS, Balusu R, Armas ML, Kundu CN, Narayan S.

Biochemistry. 2006 Dec 26;45(51):15903-14. Epub 2006 Nov 30.

30.

Cigarette smoke condensate-induced level of adenomatous polyposis coli blocks long-patch base excision repair in breast epithelial cells.

Kundu CN, Balusu R, Jaiswal AS, Gairola CG, Narayan S.

Oncogene. 2007 Mar 1;26(10):1428-38. Epub 2006 Aug 21.

PMID:
16924228
32.

Transforming growth factor -beta receptor signaling in cancer.

Narayan S, Thangasamy T, Balusu R.

Front Biosci. 2005 May 1;10:1135-45. Review.

PMID:
15769612
33.

Involvement of adenomatous polyposis coli in colorectal tumorigenesis.

Jaiswal AS, Balusu R, Narayan S.

Front Biosci. 2005 May 1;10:1118-34. Review.

PMID:
15769611
36.

Supplemental Content

Loading ...
Support Center